Drug intelligence / Profile preview

Gaxilose

Development stage
Phase 4
Lead developer
Venter Pharma
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Gaxilose is a synthetic disaccharide and small molecule diagnostic agent used primarily for the noninvasive diagnosis of hypolactasia (lactase deficiency), which underlies lactose intolerance. Structurally, it is a close analogue of lactose (specifically 4-O-β-D-galactopyranosyl-d-xylose). After oral administration, gaxilose is hydrolyzed in the intestine by the enzyme lactase into galactose and xylose. The amount of xylose excreted in urine after ingestion directly reflects intestinal lactase activity and thus serves as a quantitative marker for diagnosing hypolactasia. Gaxilose has been approved for use as a diagnostic tool in some countries under brand names such as LacTEST and Lactophan[2][4][5][6].

Brand names
LactophanLacTEST
Other names
gaxilosa4-O-galactopyranosylxylose4-O-galactosyl-D-xylose4-O-galactosylxylose
02

Targets

GLB1 (Galactosidase Beta 1)

Beyond the preview

Go deeper on Gaxilose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gaxilose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call